View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

DOJ/DEA RIN: 1117-AB50 Publication ID: Fall 2023 
Title: Amendments to the Drug Enforcement Administration Hearing Regulations 

This rule proposes to amend the Drug Enforcement Administration (DEA) hearing regulations that govern the procedures in administrative hearings to deny, revoke, or suspend a DEA registration to handle controlled substances or listed chemicals.

Agency: Department of Justice(DOJ)  Priority: Substantive, Nonsignificant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 1300 and 1301    21 CFR 1303    21 CFR 1308 and 1309    21 CFR 1312 and 1313    21 CFR 1315 and 1316    21 CFR 1321   
Legal Authority: 21 U.S.C. 875 to 877   
Legal Deadline:  None
Action Date FR Cite
NPRM  10/00/2024 
Additional Information: DEA Docket number 395
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
RIN Information URL:   Public Comment URL:  
RIN Data Printed in the FR: No 
Agency Contact:
Scott A. Brinks
Section Chief, Regulatory Drafting and Support Section, Diversion Control Division
Department of Justice
Drug Enforcement Administration
8701 Morrissette Drive,
Springfield, VA 22152
Phone:571 362-8209